文献速递主动脉疾病

主动脉内移植物感染结局劣于外科移植物或原发性感染

Aortic endograft infections have worse outcomes compared to aortic surgical grafts or primary mycotic aortic infections.
PubMed 文献 · J Vasc Surg · 2025-06-18

该单中心回顾性研究纳入2000至2022年145例原发性主动脉感染或主动脉移植物感染患者,比较原发性感染、外科移植物感染和腔内移植物感染三组结局。腔内移植物感染组住院死亡率(39% vs 15% vs 10%)和30天并发症率(68% vs 40% vs 37%)最高,原发性感染组30天、1年和5年生存率最高。多因素分析显示感染的外科移植物和腔内移植物与30天死亡率显著升高相关(HR分别为8.1和5.8)。

要点

  • 腔内移植物感染组住院死亡率和30天并发症率最高。
  • 原发性主动脉感染组30天、1年和5年生存率最高。
  • 感染的外科移植物和腔内移植物与30天死亡率升高独立相关。

核心结论

  • 感染性主动脉腔内移植物相比外科移植物和原发性主动脉感染具有更低的短期和长期生存率以及更低的长期无再干预生存率。
  • 内脏动脉受累与1年和5年死亡率增加相关,但与30天死亡率无关。
  • 需确定腔内移植物感染的预测因素以减少并发症,若担心存在潜在感染过程,行腔内主动脉干预前需仔细考虑。

研究设计与样本

  • 按感染类型分为原发性感染组(33.8%)、外科移植物感染组(44.8%)和腔内移植物感染组(21.4%)。
  • 主要结局为总生存率和无再干预生存率,采用Kaplan-Meier生存分析和Cox比例风险分析。

主要发现

  • 住院死亡率:腔内移植物组39% vs 外科移植物组15% vs 原发性感染组10%(P = .007)。
  • 30天并发症率:腔内移植物组68% vs 外科移植物组40% vs 原发性感染组37%(P = .015)。
  • Kaplan-Meier分析显示原发性主动脉感染组30天、1年和5年生存率最高。
  • 1年和5年无再干预生存率在原发性感染组最高(log-rank P < .001)。
  • 多因素分析:感染的外科移植物与30天死亡率显著升高相关(HR 8.1;P = .016),感染的腔内移植物与30天死亡率显著升高相关(HR 5.8;P = .035)。

临床怎么用

  • 对于主动脉移植物感染患者,需注意腔内移植物感染者的住院死亡率和30天并发症率最高。
  • 原发性主动脉感染者的短期和长期生存率及无再干预生存率优于移植物感染。
  • 内脏动脉受累与1年和5年死亡率增加相关,评估时应予以关注。
  • 若担心存在潜在感染过程,行腔内主动脉干预前需仔细考虑。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aortic infection is associated with high morbidity and mortality, but the outcomes of prosthetic (surgical or endovascular) grafts compared with primary aortic infections are poorly defined. This large single-center retrospective study aims to compare the outcomes of primary and prosthetic aortic graft infections. METHODS: Patients diagnosed with primary or infected aortic grafts between January 2000 and December 2022 were included. Patients were grouped based on the type of infection (primary, surgical graft, and endograft). Baseline demographics, symptoms, imaging, interventions, and outcomes were evaluated. Primary outcomes include overall and reintervention-free survival. Kaplan-Meier survival and Cox proportional hazards analysis were performed. RESULTS: A total of 145 patients presented during the study period with primary infection of the native aorta (33.8%) or aortic graft infection (66.2%: 44.8% surgical graft and 21.4% endograft). In-hospital mortality (39% vs 15% vs 10%; P = .007) and 30-day complication rates (68% vs 40% vs 37%; P = .015) were highest among endografts, followed by surgical grafts, and lowest among primary infections, respectively. Primary aortic infections had the highest 30-day, 1-year, and 5-year survival on Kaplan-Meier analysis compared with surgical and endograft infections. Reintervention-free survival was also highest in primary infections at 1 and 5 years (log-rank P < .001). On multivariate analysis, infected surgical grafts and endografts were associated with a significantly higher 30-day mortality (hazard ratio, 8.1; P = .016 and hazard ratio, 5.8; P = .035, respectively). Visceral artery involvement was a major determinant of mortality at 1 year and 5 years but not at 30 days, whereas treatment type did not affect mortality across all groups. There was no difference in the duration of intravenous antibiotic treatment between groups (42 vs 45 vs 44 days; P = .68). CONCLUSIONS: Infected aortic endografts have lower short- and long-term survival as well as a lower rate of long-term intervention-free survival when compared with surgical graft and primary aortic infections. Visceral artery involvement was associated with increased mortality. Predictors of endograft infection need to be determined to minimize complications, and careful consideration is necessary before endovascular aortic interventions if there is concern an underlying infectious process.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Xie B, Semaan DB, Alindogan N, et al. Aortic endograft infections have worse outcomes compared to aortic surgical grafts or primary mycotic aortic infections. J Vasc Surg. 2025. PMID: 40553917. doi:10.1016/j.jvs.2025.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。